Literature DB >> 27957760

Isolation and characterization of antiproliferative peptides from Chinese three-striped box turtle (Cuora trifasciata).

Xinliang Mao1,2, Shengjie He1, Ting Zhang2, Xiaolei Guo2, Yazhong Ge2, Chungwah Ma2, Xuewu Zhang1.   

Abstract

In this study, the whole proteins from a Chinese three-striped box turtle (Cuora trifasciata) were extracted and hydrolyzed using three proteases (alcalase, papain, and protamex). By orthogonal experiments, the optimal hydrolysis conditions for producing peptides with the highest cancer cells growth inhibition activity were determined. Such as, the maximum inhibition on MCF-7 cancer cells (92.37% at 1 mg/mL) was achieved by papain hydrolysis (pH 8, 37 °C, enzyme-to-substrate ratio (E/S) 1.5%), and the maximum inhibition on HepG2 cancer cells (94.16% at 1 mg/mL) was reached by protamex hydrolysis (pH 8, 40 °C, E/S 2%). Using ultrafiltration and Sephadex G-15 column chromatography, two polypeptides M2 and F4 were isolated. At 500 μg/mL, M2 exhibited 74.7% and 62.9% of antiproliferation activities on MCF-7 and HepG2 cancer cells, respectively; and F4 displayed good inhibitory effects on MCF-7 (70.59%) and HepG2 (78.6%) cancer cells. M2 and F4 had lower inhibition (<20%) than drug 5-FU (>60%) on normal liver cells L-O2. Moreover, three peptides, EMLQPPL, PGKPLFL, and SCCSCDED, were identified; their inhibitory effects on cancer cells were confirmed after synthesis. These data, for the first time, demonstrated that Cuora trifasciata-derived proteins could be used for preparing antiproliferation peptides.
© 2016 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  antiproliferation, Cuora trifasciata; hydrolysis; optimization; peptides

Mesh:

Substances:

Year:  2017        PMID: 27957760     DOI: 10.1002/bab.1548

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  1 in total

1.  Crocodylus porosus: a potential source of anticancer molecules.

Authors:  Shareni Jeyamogan; Naveed Ahmed Khan; K Sagathevan; Ruqaiyyah Siddiqui
Journal:  BMJ Open Sci       Date:  2020-10-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.